KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2026)

Hims & Hers Health's Shares Outstanding history spans 8 years, with the latest figure at $230.7 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 3.18% to $230.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $230.7 million, a 3.18% increase, with the full-year FY2025 number at $227.2 million, up 2.9% from a year prior.
  • Shares Outstanding hit $230.7 million in Q1 2026 for Hims & Hers Health, up from $227.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for HIMS hit a ceiling of $230.7 million in Q1 2026 and a floor of $8.4 million in Q3 2025.
  • Historically, Shares Outstanding has averaged $203.5 million across 5 years, with a median of $213.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 7.59% in 2022 and later increased 1.67% in 2023.
  • Tracing HIMS's Shares Outstanding over 5 years: stood at $208.4 million in 2022, then grew by 2.42% to $213.5 million in 2023, then increased by 3.45% to $220.8 million in 2024, then increased by 2.9% to $227.2 million in 2025, then grew by 1.52% to $230.7 million in 2026.
  • Business Quant data shows Shares Outstanding for HIMS at $230.7 million in Q1 2026, $227.2 million in Q4 2025, and $227.5 million in Q3 2025.